Victoza Cost in 2026: Pricing, Coverage, and Options

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub, your resource for evidence-based guidance on GLP-1 therapies and the genetic variables behind every metabolic decision. Victoza is one of the longer-established GLP-1 receptor agonists, and its cost remains one of the most frequently searched questions in the entire category. As with the rest of the class, the price you see advertised is a starting point, not the amount most insured patients actually pay.

Victoza list price as of April 2026

Victoza list price is approximately $815 per month at U.S. list price as of April 2026, per Novo Nordisk published pricing. List price is rarely what most insured patients pay; it is the figure that exists before insurance, rebates, manufacturer savings cards, and pharmacy negotiation come into play. Out-of-pocket cost varies by plan, formulary, prior authorization, and the indication written on the prescription.

Insurance and prior authorization

Commercial plan coverage of Victoza depends on whether the prescription is written for an FDA-approved indication and on the plan's formulary and prior authorization criteria. Many commercial plans cover GLP-1 receptor agonists for type 2 diabetes.

Weight management coverage is different

Coverage for chronic weight management varies more widely, is often subject to BMI-based prior authorization, and is excluded entirely by some plans. Medicare does not cover FDA-approved weight-management drugs for weight alone as of April 2026, though cardiovascular-indication coverage exists for some products. Check directly with your plan for specifics.

Manufacturer savings programs

Novo Nordisk publishes a manufacturer savings card program that, for eligible commercially-insured patients, can substantially reduce monthly out-of-pocket cost. Eligibility typically excludes Medicare, Medicaid, TRICARE, and other government-funded insurance. Savings cards carry monthly and annual caps, and both eligibility and savings amounts change, so verify current terms on the manufacturer website at the time of fill. Independent pharmacy discount platforms such as GoodRx and SingleCare also publish coupon prices that vary by pharmacy.

Compounded alternatives and what changed in 2024 to 2025

During the FDA-declared shortages of semaglutide and tirzepatide, 503A compounding pharmacies legally produced compounded formulations of those molecules. The FDA resolved the semaglutide shortage in late 2024 and the tirzepatide shortage in early 2025, which narrowed the compounding window without eliminating all legitimate compounding-pharmacy activity. Compounded semaglutide and tirzepatide remain available through licensed pathways where clinically justified. Compounded products are not identical to FDA-approved brand products and are priced separately.

What typical out-of-pocket scenarios look like

With commercial insurance that covers the indication and the savings card applied, eligible patients may pay as little as $25 per month depending on plan terms and caps. With commercial insurance that does not cover the indication, cash-pay cost is typically closer to list price minus whatever coupon applies. Without insurance, cash-pay cost approaches list price. Compounded alternatives through the PlexusDx Weight Management Protocols follow a separate pricing structure published on the relevant product pages. PlexusDx does not sell, distribute, or prescribe Victoza or any therapeutic peptide outside its own protocols, which include semaglutide and tirzepatide.

Why genetic context matters across every option

Regardless of which GLP-1 pathway compound you and your provider eventually discuss, the underlying genetic architecture is the same. The Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights, including variants in FTO, GLP1R, and MC4R that shape baseline GLP-1, appetite-regulation, and energy-balance biology. It does not predict response to any specific medication and is not a pharmacogenomic test. Knowing that profile before committing to any protocol turns guesswork into a better-informed provider conversation.

How to compare your real options

Because the advertised figure and the counter price can diverge so sharply, comparing Victoza options is less about chasing a headline number and more about understanding your own coverage. It helps to confirm the indication on your prescription, check whether your plan lists the product on its formulary, and ask whether prior authorization applies. From there, a savings card, an independent coupon, or a licensed compounded alternative may each land at a different price point. Prices and program terms change over time, so a quote from months ago may be outdated. Confirming details with the pharmacy at the time of fill gives you the most accurate picture of what you will actually pay.

Frequently Asked Questions

How much does Victoza cost per month?

Victoza list price is approximately $815 per month at U.S. list price as of April 2026, per Novo Nordisk published pricing. Insurance, savings cards, and pharmacy pricing can substantially change what a patient actually pays at the counter, so verify the current price with the pharmacy before you fill.

Does insurance cover Victoza?

Coverage depends on the plan, formulary, FDA indication on the prescription, and prior authorization criteria. Many commercial plans cover GLP-1 receptor agonists for type 2 diabetes, while chronic weight management coverage is more variable. Medicare does not cover weight-management indications for weight alone as of April 2026.

Are there lower-cost alternatives to Victoza?

Licensed compounding pharmacies produce compounded semaglutide and tirzepatide formulations at separate price points from FDA-approved brand products. Compounded products are legally and factually different, not identical and not generics. PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols with pricing published on each product page.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.